Market Cap (In INR)
49.49 Billion
Revenue (In INR)
17.84 Billion
Net Income (In INR)
696 Million
Avg. Volume
621.26 Thousand
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 260.3-464.75
- PE
- -
- EPS
- -
- Beta Value
- 1.251
- ISIN
- INE475B01022
- CUSIP
- Y3195T157
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Jai Vishwanath Hiremath
- Employee Count
- -
- Website
- https://www.hikal.com
- Ipo Date
- 2002-07-01
- Details
- Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal healthcare, biotech, crop protection, and specialty chemicals companies. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredient (APIs). The Crop Protection segment manufactures pesticides and herbicides. The company collaborates with other companies and offer solutions in contract research, custom synthesis, and custom manufacturing of intermediates and APIs. It also provides specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company was incorporated in 1988 and is headquartered in Navi Mumbai, India.
More Stocks
-
8075Shinsho Corporation
8075
-
KC
-
SZKMYSuzuki Motor Corporation
SZKMY
-
SGNLFSignal Gold Inc.
SGNLF
-
INDRAMEDCOIndraprastha Medical Corporation Limited
INDRAMEDCO
-
CBECobre Limited
CBE
-
NKRKFNokian Renkaat Oyj
NKRKF
-
KWE